Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer

NCT07720167 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Cemiplimab
DRUG: Carboplatin + Pemetrexed/Paclitaxel
DRUG: Cisplatin

Sponsor

Medical University of South Carolina